US 12,444,515 B2
Device and method for producing medical isotopes
Gregory Piefer, Janesville, WI (US)
Assigned to SHINE Technologies, LLC, Janesville, WI (US)
Filed by SHINE Technologies, LLC, Janesville, WI (US)
Filed on Apr. 15, 2022, as Appl. No. 17/722,176.
Application 17/722,176 is a division of application No. 15/644,497, filed on Jul. 7, 2017, granted, now 11,830,637.
Application 15/644,497 is a continuation of application No. 12/990,758, granted, now 9,734,926, issued on Aug. 15, 2017, previously published as PCT/US2009/042587, filed on May 1, 2009.
Claims priority of provisional application 61/050,096, filed on May 2, 2008.
Prior Publication US 2022/0270775 A1, Aug. 25, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. G21G 1/08 (2006.01); G21B 1/01 (2006.01); G21C 1/30 (2006.01)
CPC G21G 1/08 (2013.01) [G21B 1/01 (2013.01); G21C 1/303 (2013.01); Y02E 30/10 (2013.01); Y02E 30/30 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A hybrid reactor comprising:
a fusion portion comprising a gas target neutron generator having an annular target chamber,
the annular target chamber encircling a space, the gas target neutron generator operable to produce a neutron flux within the space; and
a fission portion comprising a cylindrical activation cell disposed within the space and adjacent the annular target chamber, the cylindrical activation cell comprising:
an outer annular vessel comprising a parent material in aqueous solution, the parent material configured to react with a portion of the neutron flux to produce a medical isotope during a fission reaction, and
an inner cylindrical volume comprising an attenuator configured to maintain the fission reaction at a subcritical level.